←Back to Expert Scholars
Translational Medicine / 转化医学DNA Methylation, Epigenetic Therapy
Peter Jones
PhD
🏢Van Andel Institute🌐USA
Chief Scientific Officer (Emeritus)
145
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Peter Jones helped discover that azacitidine inhibits DNA methyltransferase and has been a foundational voice in cancer epigenetics. He co-founded the Van Andel-Stand Up To Cancer epigenetics Dream Team and led early combination trials. He mentors a large translational network.
Share:
🧪Research Fields 研究领域
DNA methylation
azacitidine mechanism
epigenetic therapy
cancer epigenetics
chromatin
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Peter Jones 的研究动态
Follow Peter Jones's research updates
留下邮箱，当我们发布与 Peter Jones（Van Andel Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment